Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
During trials of preventive HIV vaccines, trial participants may develop HIV-related antibody responses that could lead to a positive HIV test by routine antibody detection methods (called vaccine-induced seropositivity/reactivity), and the potential for false-positive test results and an incorrect HIV diagnosis, according to a study in the July 21 issue of the Journal of the American Medical Association, a theme issue on HIV.
Lindsey R. Baden, MD, of Brigham and Women's Hospital and Harvard Medical School, Boston, presented the findings of the study at a JAMA media briefing at the International AIDS conference in Vienna.
"With an estimated 7,500 new human immunodeficiency virus infections occurring each day worldwide, there is an urgent need to develop an effective prophylactic HIV vaccine. Over the past 20 years many potential vaccine candidates have been developed and assessed in human clinical trials in more than 30,000 participants."
The researchers add that induction of protective anti-HIV immune responses is the goal of an HIV vaccine. However, this may cause a reactive result in routine HIV testing in the absence of HIV infection, and has the potential of confounding factors that can improperly skew outcomes interpretation of HIV tests because of the antibody induced by vaccination. "Participants in early phase clinical trials, who are typically at low risk of HIV infection," the continue, "may encounter difficulties with obtaining medical or disability/life insurance, donating blood or organs, employment, and immigration owing to a false-positive HIV test result."
Baden and colleagues assessed the occurrence of vaccine-induced seropositivity, or VISP, associated with different vaccine delivery systems and HIV inserts studied by the HIV Vaccine Trials Network. Three common U.S. Food and Drug Administration-approved enzyme immunoassay HIV antibody kits were used to determine VISP, and a routine diagnostic HIV algorithm was used to evaluate VISP frequency in healthy, HIV-seronegative adults who completed phase I and phase IIa vaccine trials conducted from 2000 to 2010 in the United States, South America, Thailand, and Africa. The majority of participants (82%) in the analysis were from the United States.
VISP occurred in 908 of 2,176 participants (41.7%). Rates of VISP varied greatly by type of HIV vaccine administered. For poxvirus products given alone or as a boost to a DNA or poxvirus prime, 53.4% (295 of 552) of recipients had VISP; 86.7% (399 of 460) of adenovirus 5 product recipients developed VISP, as did 35 of 555 (6.3%) of DNA-alone product recipients.
Overall, the proportion of VISP among the various HIV testing kits tested ranged from about 41% to 9%. The researchers also found that among the 901 participants with VISP and a Western blot result (a technique in molecular biology, used to separate and identify proteins), 92 (10.2%) had a positive result, 592 (65.7%) tested indeterminate, and 217 (24.1%) tested negative; however, the distribution of results varied by product.
"These data demonstrate that VISP is a common but highly variable outcome of trials of preventive HIV vaccines," the authors write. "Because participants with VISP may subsequently become infected with HIV, it is imperative that appropriate follow-up testing be conducted, including HIV RNA testing, to minimize potential misinterpretation of HIV test results."
"Testing for VISP at the end of the study and providing participants with their VISP status is critically important to prevent social harms, incorrect HIV diagnosis, and inaccurate reporting to health agencies. A misinterpretation of VISP can be minimized by clinicians obtaining a complete patient history (e.g., participation in an HIV vaccine trial) and interpretation of the Western blot and HIV RNA."
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus: Featured Video
Latest Stories
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM